Sinonasal diseases, such as rhinosinusitis, affect up to 12% of individuals each year which
constitutes these diseases as some of the most common medical conditions in the world …

Severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) is the causative agent
of COVID-19 which was detected in late 2019 in Wuhan, China. As of September 2022 …

Olfactory disorders (OD) pathogenesis, underlying conditions, and prognostic in coronavirus
disease 2019 (COVID‐19) remain partially described. ANOSVID is a retrospective study in …

During the first waves of the coronavirus disease 2019 (COVID-19) pandemic caused by
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, olfactory …

Since the worldwide spread of SARS-CoV-2 infection, the management of COVID-19 has
been a challenge for healthcare professionals. Although the respiratory system has primarily …

Background Olfactory and gustatory dysfunctions are early symptoms of SARS-CoV-2
infection. Between 20–80% of infected individuals report subjective altered sense of smell …

Background: After a severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)
infection, smell disorders frequently occur, significantly affecting patients' quality of life (QoL) …

Background. Long-term evolution data of olfactory disorders (OD) in COVID-19 are limited.
Method. ANOSVID is a retrospective study in Nord Franche-Comté Hospital (France) that …

Abstract Background Coronavirus disease 2019 (COVID-19) has been associated with
nervous system involvement, with more than one-third of COVID-19 patients experiencing …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has affected the
entire world, causing the coronavirus disease 2019 (COVID-19) pandemic since it was first …